Bharat Biotech Ltd., a prominent player in the biotechnology sector, is headquartered in Hyderabad, India. Founded in 1996, the company has established itself as a leader in vaccine development and biopharmaceuticals, focusing on innovative solutions for infectious diseases. With a robust portfolio that includes vaccines for diseases such as typhoid, hepatitis, and COVID-19, Bharat Biotech is renowned for its commitment to research and development. The company’s unique approach combines cutting-edge technology with a strong emphasis on safety and efficacy, setting it apart in the competitive landscape. Recognised for its significant contributions to public health, Bharat Biotech has achieved notable milestones, including the development of India’s first indigenous COVID-19 vaccine. Its strategic operations extend across various regions, reinforcing its position as a key player in the global biotechnology industry.
How does Bharat Biotech Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bharat Biotech Ltd.'s score of 14 is lower than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bharat Biotech Ltd., headquartered in India, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges. In the absence of specific emissions data or commitments, it is important to note that many organisations in the biotechnology sector are increasingly focusing on sustainability and climate action. This includes setting science-based targets and engaging in initiatives aimed at reducing their carbon footprint. However, without concrete data or commitments from Bharat Biotech Ltd., it is unclear how they align with these industry trends. As the company continues to operate, it may consider adopting industry-standard climate strategies to enhance its environmental performance and contribute to global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bharat Biotech Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
